Tyler Dylan-Hyde, Chief Legal Officer at CRISPR Therapeutics AG (CRSP), sold 38,000 shares at $25.75 ($823K) on 2018-01-02, disclosed to the SEC on 2018-01-04.
Open-market sale of $822k CRSP by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.55 | 30,000 | $617K | 75.0% |
| 2 | $25.75 | 8,000 | $206K | 25.0% |
| Total | $21.64 avg | 38,000 | $823K | 100% |
| Filing → |
| CRSP | SELL | 2017-12-27 | $308K | — | Filing → |
| CRSP | SELL | 2017-12-19 | $284K | — | Filing → |
| CRSP | SELL | 2017-08-08 | $524K | — | Filing → |